Abstract:
Diabetes mellitus is a common endocrine disorder in companion animals, associated with systemic metabolic disturbances
and gut microbiota alterations. Recent studies highlight that diabetic dogs and cats exhibit reduced microbial diversity,
decreased short-chain fatty acid (SCFA)–producing bacteria, and increased opportunistic microorganisms. Probiotic and
synbiotic interventions have been explored as potential adjunctive therapies to modulate gut microbiota, improve
metabolic parameters, and support insulin sensitivity. Evidence indicates that probiotics can partially restore microbial
balance, enhance SCFA production, reduce systemic inflammation, and improve glycemic control. Synbiotics, combining
prebiotics and probiotics, may provide synergistic benefits by promoting beneficial bacterial growth and reinforcing
intestinal barrier integrity. Additionally, probiotic-based diets may indirectly support oral health, an important
consideration given the bidirectional relationship between periodontal disease and diabetes in companion animals.
However, the majority of studies are limited by small sample sizes, heterogeneous formulations, and short-term
interventions. Long-term effects on insulin therapy requirements, diabetic complications, and comorbidities remain
largely unexplored. Host factors such as age, diet, genetics, and environment also influence individual responses,
underscoring the need for personalized approaches. Translational insights from human research provide mechanistic
support and guidance for strain selection, dosage, and intervention strategies. Overall, probiotic-based dietary strategies
show promising metabolic and microbial benefits but require further species-specific, long-term studies to establish
standardized clinical protocols and confirm efficacy.
